Viewing Study NCT05487560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-02-04 @ 9:20 AM
Study NCT ID: NCT05487560
Status: COMPLETED
Last Update Posted: 2022-08-04
First Post: 2022-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + … View
Keywords: